# Pomalidomide/Cyclophosphamide/Dexamethasone in Relapse Refractory Myeloma: Safety Profile in Mexicans

> **NCT03601624** · PHASE2 · UNKNOWN · sponsor: **Instituto de Seguridad y Servicios Sociales de los Trabajadores del Estado** · enrollment: 18 (estimated)

## Conditions studied

- Multiple Myeloma in Relapse
- Multiple Myeloma Progression
- Refractory Multiple Myeloma

## Interventions

- **DRUG:** Pomalidomide

## Key facts

- **NCT ID:** NCT03601624
- **Lead sponsor:** Instituto de Seguridad y Servicios Sociales de los Trabajadores del Estado
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2018-09-01
- **Primary completion:** 2018-12-31
- **Final completion:** 2020-07-30
- **Target enrollment:** 18 (ESTIMATED)
- **Last updated:** 2018-11-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03601624

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03601624, "Pomalidomide/Cyclophosphamide/Dexamethasone in Relapse Refractory Myeloma: Safety Profile in Mexicans". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT03601624. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*